| Dr Melissa J Aldy, DDS | |
|
363 S Acadian Thruway, Baton Rouge, LA 70806-5022 | |
| (225) 389-0040 | |
| (225) 389-0041 |
| Full Name | Dr Melissa J Aldy |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 363 S Acadian Thruway, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144355058 | NPI | - | NPPES |
| 1850063 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 5006 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa J Aldy, DDS 363 S Acadian Thruway, Baton Rouge, LA 70806-5022 Ph: (225) 389-0040 | Dr Melissa J Aldy, DDS 363 S Acadian Thruway, Baton Rouge, LA 70806-5022 Ph: (225) 389-0040 |
News Archive
Results from a six-month, multi-site clinical trial called the Wireless Innovation for Seniors with Diabetes Mellitus Study Group have been published by the Journal of the American Medical Association.
NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles focused on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with NeuroSigma's external trigeminal nerve stimulation (eTNS) System.
GenVec, Inc, announced today that SAIC-Frederick, Inc. has signed a contract with GenVec for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Japanese researchers reveal an association between elevated FIB-4 index 24 weeks after the initiation of nucleos(t)ide analogue therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
NanoBio Corporation today announced compelling preclinical data for NB-401, a nebulized nanoemulsion-based agent that kills highly drug-resistant strains of bacteria commonly found in cystic fibrosis patients. Currently there are limited treatment options available that effectively address these resistant bacteria. The study results are being presented today at the 2009 Annual North American Cystic Fibrosis Conference (NACFC) in Minneapolis, Minn.
› Verified 6 days ago
Dr. Rachel Elizabeth Dier, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 12045 Coursey Blvd, Baton Rouge, LA 70816 Phone: 225-292-8789 | |
Dr. Hoang Van Tran, DDS Dentist Medicare: Medicare Enrolled Practice Location: 10914 Old Hammond Hwy, Baton Rouge, LA 70816 Phone: 225-615-7334 Fax: 225-615-7986 | |
Dr. Michael E Hiller, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4607 Sherwood Common Blvd, Baton Rouge, LA 70816 Phone: 225-924-7367 Fax: 225-929-9506 | |
Dr. Billy George Hall Jr., D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 5151 Plank Rd, Suite 28, Baton Rouge, LA 70805 Phone: 225-330-6688 Fax: 225-356-8163 | |
Dr. Jana Elaine Boyd, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 11930 S Harrells Ferry Rd, Baton Rouge, LA 70816 Phone: 225-928-5920 | |
James M Hayden, DDS Dentist Medicare: Medicare Enrolled Practice Location: 8160 Ymca Plaza Dr, Suite B, Baton Rouge, LA 70810 Phone: 225-768-8200 Fax: 225-768-8070 | |
Dr. Kredenna Beverly, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2314 Weymouth Dr., Ste. B, Baton Rouge, LA 70809 Phone: 225-926-4444 Fax: 225-926-4050 |